These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2460640)
1. Minimum requirements for immunogenic and antigenic activities of homologs of a synthetic peptide of influenza virus hemagglutinin. Tang XL; Tregear GW; White DO; Jackson DC J Virol; 1988 Dec; 62(12):4745-51. PubMed ID: 2460640 [TBL] [Abstract][Full Text] [Related]
2. Antigenic determinants of influenza virus hemagglutinin. XII. the epitopes of a synthetic peptide representing the C-terminus of HA1. Jackson DC; Tang XL; Brown LE; Murray JM; White DO; Tregear GW Virology; 1986 Dec; 155(2):625-32. PubMed ID: 2431541 [TBL] [Abstract][Full Text] [Related]
3. Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution. Schoofs PG; Geysen HM; Jackson DC; Brown LE; Tang XL; White DO J Immunol; 1988 Jan; 140(2):611-6. PubMed ID: 2447184 [TBL] [Abstract][Full Text] [Related]
4. The intersubunit region of the influenza virus haemagglutinin is recognized by antibodies during infection. Nagy Z; Rajnavölgyi E; Hollósi M; Tóth GK; Váradi G; Penke B; Tóth I; Horváth A; Gergely J; Kurucz I Scand J Immunol; 1994 Sep; 40(3):281-91. PubMed ID: 8091127 [TBL] [Abstract][Full Text] [Related]
5. A single amino acid substitution in influenza hemagglutinin abrogates recognition by monoclonal antibody and a spectrum of subtype-specific L3T4+ T cell clones. Thomas DB; Skehel JJ; Mills KH; Graham CM Eur J Immunol; 1987 Jan; 17(1):133-6. PubMed ID: 2434337 [TBL] [Abstract][Full Text] [Related]
6. Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein. Staneková Z; Király J; Stropkovská A; Mikušková T; Mucha V; Kostolanský F; Varečková E Acta Virol; 2011; 55(1):61-7. PubMed ID: 21434706 [TBL] [Abstract][Full Text] [Related]
7. Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites. Nestorowicz A; Tregear GW; Southwell CN; Martyn J; Murray JM; White DO; Jackson DC Mol Immunol; 1985 Feb; 22(2):145-54. PubMed ID: 2579329 [TBL] [Abstract][Full Text] [Related]
8. A synthetic decapeptide of influenza virus hemagglutinin elicits helper T cells with the same fine recognition specificities as occur in response to whole virus. Hackett CJ; Hurwitz JL; Dietzschold B; Gerhard W J Immunol; 1985 Aug; 135(2):1391-4. PubMed ID: 2409149 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the antigenic profile of measles virus haemagglutinin in mice and humans using overlapping synthetic peptides. Obeid OE; Partidos CD; Steward MW Virus Res; 1994 Apr; 32(1):69-84. PubMed ID: 7518172 [TBL] [Abstract][Full Text] [Related]
10. Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin. Wabuke-Bunoti MA; Taku A; Fan DP; Kent S; Webster RG J Immunol; 1984 Oct; 133(4):2194-201. PubMed ID: 6206156 [TBL] [Abstract][Full Text] [Related]
11. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin. Brown LE; Murray JM; White DO; Jackson DC Arch Virol; 1990; 114(1-2):1-26. PubMed ID: 1699509 [TBL] [Abstract][Full Text] [Related]
12. Immunogenic structure of the influenza virus hemagglutinin. Green N; Alexander H; Olson A; Alexander S; Shinnick TM; Sutcliffe JG; Lerner RA Cell; 1982 Mar; 28(3):477-87. PubMed ID: 6176330 [TBL] [Abstract][Full Text] [Related]
13. Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus. Ffrench RA; Tang XL; Anders EM; Jackson DC; White DO; Drummer H; Wade JD; Tregear GW; Brown LE J Virol; 1989 Jul; 63(7):3087-94. PubMed ID: 2786093 [TBL] [Abstract][Full Text] [Related]
14. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794 [TBL] [Abstract][Full Text] [Related]
15. Genetic control and fine specificity of the immune response to a synthetic peptide of influenza virus hemagglutinin. Brown LE; Murray JM; Anders EM; Tang XL; White DO; Tregear GW; Jackson DC J Virol; 1988 May; 62(5):1746-52. PubMed ID: 3258640 [TBL] [Abstract][Full Text] [Related]
16. I-Ad restricted T cell recognition of influenza hemagglutinin. Synthetic peptides identify multiple epitopes corresponding to antibody-binding regions of the HA1 subunit. Barnett BC; Burt DS; Graham CM; Warren AP; Skehel JJ; Thomas DB J Immunol; 1989 Oct; 143(8):2663-9. PubMed ID: 2477451 [TBL] [Abstract][Full Text] [Related]
17. Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutinin. Hioe CE; Dybdahl-Sissoko N; Philpott M; Hinshaw VS J Virol; 1990 Dec; 64(12):6246-51. PubMed ID: 1700833 [TBL] [Abstract][Full Text] [Related]
18. A novel approach for localization of the continuous protein antigenic sites by comprehensive synthetic surface scanning: antibody and T-cell activity to several influenza hemagglutinin synthetic sites. Atassi MZ; Kurisaki J Immunol Commun; 1984; 13(6):539-51. PubMed ID: 6085322 [TBL] [Abstract][Full Text] [Related]